Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1366

1.

The optimal chemotherapeutic regimen in D2-resected locally advanced gastric cancer: a propensity score-matched analysis.

Hwang JE, Ki MS, Kim K, Jung SH, Shim HJ, Bae WK, Hwang EC, Hur YH, Jeong O, Ryu SY, Park YK, Cho SH, Lee JS, Chung IJ.

Oncotarget. 2017 Mar 16;8(39):66559-66568. doi: 10.18632/oncotarget.16301. eCollection 2017 Sep 12.

2.

Is preoperative chronic kidney disease status associated with oncologic outcomes in upper urinary tract urothelial carcinoma? A multicenter propensity score-matched analysis.

Yu HS, Hwang JE, Chung HS, Cho YH, Kim MS, Chang Hwang E, Oh KJ, Kim SO, Jung SI, Kang TW, Kwon DD, Park K, Ryu SB, Jung SH, Hur YH, Noh JH, Kim MK, Seo IY, Kim CS, Kang SG, Kang SH, Cheon J.

Oncotarget. 2017 Mar 15;8(39):66540-66549. doi: 10.18632/oncotarget.16239. eCollection 2017 Sep 12.

3.

Low-power laser irradiation inhibits PDGF-BB-induced migration and proliferation via apoptotic cell death in vascular smooth muscle cells.

Baek S, Lee KP, Cui L, Ryu Y, Hong JM, Kim J, Jung SH, Bae YM, Won KJ, Kim B.

Lasers Med Sci. 2017 Oct 5. doi: 10.1007/s10103-017-2338-z. [Epub ahead of print]

PMID:
28983687
4.

Crotonis Fructus Extract Inhibits 12-O-Tetradecanoylphorbol-13-Acetate-Induced Expression of Matrix Metalloproteinase-9 via the Activator Protein-1 Pathway in MCF-7 Cells.

Song HK, Lee GS, Park SH, Noh EM, Kim JM, Ryu DG, Jung SH, Youn HJ, Lee YR, Kwon KB.

J Breast Cancer. 2017 Sep;20(3):234-239. doi: 10.4048/jbc.2017.20.3.234. Epub 2017 Sep 22.

5.

Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer.

Sun JM, Noh JM, Oh D, Kim HK, Lee SH, Choi YS, Pyo H, Ahn JS, Jung SH, Chan Ahn Y, Kim J, Ahn MJ, Zo JI, Shim YM, Park K.

J Thorac Oncol. 2017 Sep 26. pii: S1556-0864(17)32708-9. doi: 10.1016/j.jtho.2017.09.1954. [Epub ahead of print]

PMID:
28962948
6.

A systematic proteogenomic approach to exploring a novel function for NHERF1 in human reproductive disorder: lessons for exploring missing proteins.

Na K, Shin H, Cho JY, Jung SH, Lim J, Lim JS, Kim EA, Kim HS, Kang AR, Kim JH, Shin JM, Jeong SK, Kim CY, Park JY, Chung HM, Omenn GS, Hancock WS, Paik YK.

J Proteome Res. 2017 Sep 29. doi: 10.1021/acs.jproteome.7b00146. [Epub ahead of print]

PMID:
28960081
7.

Coronary artery bypass grafting in patients with severe chronic kidney disease: a propensity score-weighted analysis on the impact of on-pump versus off-pump strategies.

Kim HJ, Kim JB, Jung SH, Choo SJ, Lee JW, Chung CH.

Eur J Cardiothorac Surg. 2017 Sep 11. doi: 10.1093/ejcts/ezx288. [Epub ahead of print]

PMID:
28958042
8.

DJ-1 Regulates Differentiation of Human Mesenchymal Stem Cells into Smooth Muscle-like Cells in Response to Sphingosylphosphorylcholine.

Baek S, Lee KP, Jung SH, Cui L, Ko K, Kim B, Won KJ.

Proteomics. 2017 Sep 26. doi: 10.1002/pmic.201700208. [Epub ahead of print]

PMID:
28949093
9.

Clinical importance of TERT overexpression in hepatocellular carcinoma treated with curative surgical resection in HBV endemic area.

Il Yu J, Choi C, Ha SY, Park CK, Kang SY, Joh JW, Paik SW, Kim S, Kim M, Jung SH, Park HC.

Sci Rep. 2017 Sep 25;7(1):12258. doi: 10.1038/s41598-017-12469-2.

10.

Prognostic Factors of Orbital Fractures with Muscle Incarceration.

Lee SC, Park SH, Han SK, Yoon ES, Dhong ES, Jung SH, You HJ, Kim DW.

Arch Plast Surg. 2017 Sep;44(5):407-412. doi: 10.5999/aps.2017.44.5.407. Epub 2017 Sep 15.

11.

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).

Martin P, Jung SH, Pitcher B, Bartlett NL, Blum KA, Shea T, Hsi ED, Ruan J, Smith SE, Leonard JP, Cheson BD.

Ann Oncol. 2017 Aug 31. doi: 10.1093/annonc/mdx496. [Epub ahead of print]

PMID:
28945884
12.

Comparison of shoulder strength in males with and without myofascial trigger points in the upper trapezius.

Kim HA, Hwang UJ, Jung SH, Ahn SH, Kim JH, Kwon OY.

Clin Biomech (Bristol, Avon). 2017 Sep 6;49:134-138. doi: 10.1016/j.clinbiomech.2017.09.001. [Epub ahead of print]

PMID:
28934634
13.

Effectiveness of cholangioscopy using narrow band imaging for hepatobiliary malignancies.

Jang JW, Noh DH, Paik KH, Kim SH, Paik IH, Jung SH.

Ann Surg Treat Res. 2017 Sep;93(3):125-129. doi: 10.4174/astr.2017.93.3.125. Epub 2017 Aug 30.

14.

Disease progression patterns of bevacizumab responders with recurrent malignant gliomas.

Kim JH, Jung TY, Hwang EC, Jung SH, Jung S, Kim IY, Jang WY, Moon KS, Lee KH, Kim SK.

Oncol Lett. 2017 Sep;14(3):3529-3535. doi: 10.3892/ol.2017.6630. Epub 2017 Jul 20.

15.

Iodized Oil Transarterial Chemoembolization and Radiofrequency Ablation for Small Periportal Hepatocellular Carcinoma: Comparison with Nonperiportal Hepatocellular Carcinoma.

Lee SY, Hyun D, Cho SK, Shin SW, Jung SH, Chi SA.

Cardiovasc Intervent Radiol. 2017 Sep 18. doi: 10.1007/s00270-017-1783-1. [Epub ahead of print]

PMID:
28924943
16.

Reliability and criterion validity of measurements using a smart phone-based measurement tool for the transverse rotation angle of the pelvis during single-leg lifting.

Jung SH, Kwon OY, Jeon IC, Hwang UJ, Weon JH.

Physiother Theory Pract. 2017 Sep 18:1-8. doi: 10.1080/09593985.2017.1368756. [Epub ahead of print]

PMID:
28922042
17.

Divergence in Morris Water Maze-Based Cognitive Performance under Chronic Stress Is Associated with the Hippocampal Whole Transcriptomic Modification in Mice.

Jung SH, Brownlow ML, Pellegrini M, Jankord R.

Front Mol Neurosci. 2017 Aug 30;10:275. doi: 10.3389/fnmol.2017.00275. eCollection 2017.

18.

Recent development of signaling pathways inhibitors of melanogenesis.

Pillaiyar T, Manickam M, Jung SH.

Cell Signal. 2017 Sep 12;40:99-115. doi: 10.1016/j.cellsig.2017.09.004. [Epub ahead of print] Review.

PMID:
28911859
19.

Risk factor analysis for nonocclusive mesenteric ischemia following cardiac surgery: A case-control study.

Lim JY, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW.

Medicine (Baltimore). 2017 Sep;96(37):e8029. doi: 10.1097/MD.0000000000008029.

20.

Phase II Cancer Clinical Trials for Biomarker-Guided Treatments.

Jung SH.

J Biopharm Stat. 2017 Sep 13. doi: 10.1080/10543406.2017.1372777. [Epub ahead of print]

PMID:
28902567

Supplemental Content

Loading ...
Support Center